+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Innovative, Generic), by Dosage Form (Injectable, Creams), by Application, by Synthesis, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 220 Pages
  • August 2022
  • Region: Global
  • Grand View Research
  • ID: 5649397
Description Jump to:
The global high potency API contract manufacturing market size is expected to reach USD 14.65 billion by 2030, registering a CAGR of 9.0% over the forecast period, according to this report. The main drivers of this market are rising demand for oncology drugs, advancements in manufacturing technology, and a rise in capacity to meet the increasing demand. Also, a rise in target therapies to cure chronic diseases is going to accelerate industry growth. The COVID-19 pandemic boosted the demand for high potency APIs (HPAPIs). During the first half of the pandemic, the supply chain was disrupted, which reduced research-based activities.

However, during the second half, the industry started to gain importance due to a rise in demand for vaccines to fight the coronavirus. This rise has also increased the demand for raw materials and product intermediates of API molecules. Moreover, the growing demand for HPAPI molecules during the COVID-19 pandemic has led to the price hike of the same, thus boosting revenue growth in 2020 and 2021. There has been a rise in the outsourcing activities of high potency active pharmaceuticals as it removes the need for investment in expensive infrastructure for containing it.

Also, the installation & maintenance of the facility is complex and requires specialized engineers. The high cost of producing high potency API in-house, combined with the pressure to produce affordable drugs, has significantly contributed to the increasing outsourcing activities by companies. A wide range of outsourcing providers offers HPAPI services, thus making it difficult for companies to choose an appropriate CDMO. The large-scale CDMOs become the most likely choice as they provide large volumes. However, due to the small volumes required for dosage, small-scale providers are also gaining importance.

High Potency API Contract Manufacturing Market Report Highlights

  • The product type segment is classified into innovative and generic. The innovative segment accounted for the largest revenue share in 2021
  • Based on applications, the oncology segment dominated the industry in 2021 due to a rise in research on new cancer drugs and therapies
  • The oral solids dosage form segment is anticipated to witness the fastest growth rate during the forecast period
  • By synthesis, the industry is classified into synthetic and biotech. The biotech segment is estimated to witness a significant growth rate from 2022 to 2030
  • The Asia Pacific region is estimated to register the fastest CAGR during the forecast period due to the presence of the largest manufacturers of APIs across the globe, such as China


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product Type
1.1.2. Application
1.1.3. Synthesis
1.1.4. Dosage Form
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Volume price analysis (Model 2)
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.9.3. Objective 3
1.9.4. Objective 4
Chapter 2. Executive Summary
2.1. Market Outlook
Chapter 3. High Potency API (HPAPI) Contract Manufacturing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1 Increasing pipeline of pharmaceutical drugs
3.3.1.2 Growing expansion of HPAPI production facilities
3.3.1.3 Increasing trend of outsourcing
3.3.1.4 Increasing application of HPAPIs
3.3.2. Market restraint analysis
3.3.2.1 Significant investments and complicated safety and handling specifications associated with the production of HPAPIs
3.3. Penetration & Growth Prospect Mapping
3.4. Covid-19 Impact & Recovery Analysis
3.5. Major Deals and Strategic Alliances Analysis
3.6. Industry Analysis - Porter’s
3.7. PESTLE Analysis
Chapter 4. High Potency API (HPAPI) Contract Manufacturing Market: Product Type Segment Analysis
4.1. High Potency API (HPAPI) Contract Manufacturing Market: Definition & Scope
4.2. High Potency API (HPAPI) Contract Manufacturing Market: Product Type Market Share Analysis, 2021 & 2030
4.2.1. Innovative
4.2.1.1. Innovative Market, 2018 - 2030 (USD Million)
4.2.2. Generic
4.2.2.1. Generic Market, 2018 - 2030 (USD Million)
Chapter 5. High Potency API (HPAPI) Contract Manufacturing Market: Application Segment Analysis
5.1. High Potency API (HPAPI) Contract Manufacturing Market: Definition & Scope
5.2. High Potency API (HPAPI) Contract Manufacturing Market: Application Market Share Analysis, 2021 & 2030
5.2.1. Oncology
5.2.1.1. Oncology Market, 2018 - 2030 (USD Million)
5.2.2. Hormonal Disorders
5.2.2.1. Hormonal disorders Market, 2018 - 2030 (USD Million)
5.2.3. Glaucoma
5.2.3.1. Glaucoma Market, 2018 - 2030 (USD Million)
5.2.4. Others
5.2.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. High Potency API (HPAPI) Contract Manufacturing Market: Synthesis Segment Analysis
6.1. High Potency API (HPAPI) Contract Manufacturing Market: Definition & Scope
6.2. High Potency API (HPAPI) Contract Manufacturing Market: Synthesis Market Share Analysis, 2021 & 2030
6.2.1. Synthetic
6.2.1.1. Synthetic Market, 2018 - 2030 (USD Million)
6.2.2. Biotech
6.2.2.1. Biotech Market, 2018 - 2030 (USD Million)
Chapter 7. High Potency API (HPAPI) Contract Manufacturing Market: Dosage Form Segment Analysis
7.1. High Potency API (HPAPI) Contract Manufacturing Market: Definition & Scope
7.2. High Potency API (HPAPI) Contract Manufacturing Market: Dosage form Market Share Analysis, 2021 & 2030
7.2.1. InjecTable
7.2.1.1. InjecTable Market, 2018 - 2030 (USD Million)
7.2.2. Oral Solids
7.2.2.1. Oral solids Market, 2018 - 2030 (USD Million)
7.2.3. Creams
7.2.3.1. Creams Market, 2018 - 2030 (USD Million)
7.2.4. Others
7.2.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. High Potency API (HPAPI) Contract Manufacturing Market: Regional Analysis
8.1. Healthcare Finance Solutions: Regional market share analysis, 2021 & 2030
8.2. North America
8.2.1. North America High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.3.2. U.K.
8.3.2.1. U.K. High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.3.4. Italy
8.3.4.1. Italy High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.3.5. Spain
8.3.5.1. Spain High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
8.3.6. France
8.3.6.1. France High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
8.4.2. China
8.4.2.1. China High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.4.3. India
8.4.3.1. India High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
8.4.4. Japan
8.4.4.1. Japan High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
8.4.5. Australia
8.4.5.1. Australia High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
8.5. Latin America
8.5.1. Latin America High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
8.5.2. Brazil
8.5.2.1. Brazil High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Mexico High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Argentina High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. MEA High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.6.3. South Arabia
8.6.3.1. South Africa High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Profiles
9.1.1. Piramal Pharma Solutions
9.1.1.1. Company overview
9.1.1.2. Financial performance
9.1.1.3. Service benchmarking
9.1.1.4. Strategic initiatives
9.1.2. Lonza
9.1.2.1. Company overview
9.1.2.2. Financial performance
9.1.2.3. Service benchmarking
9.1.2.4. Strategic initiatives
9.1.3. Catalent Inc
9.1.3.1. Company overview
9.1.3.2. Financial performance
9.1.3.3. Service benchmarking
9.1.3.4. Strategic initiatives
9.1.4. VxP Pharma, Inc.
9.1.4.1. Company overview
9.1.4.2. Financial performance
9.1.4.3. Service benchmarking
9.1.4.4. Strategic initiatives
9.1.5. Pfizer CentreOne
9.1.5.1. Company overview
9.1.5.2. Financial performance
9.1.5.3. Service benchmarking
9.1.5.4. Strategic initiatives
9.1.6. Gentec Pharmaceutical Group
9.1.6.1. Company overview
9.1.6.2. Financial performance
9.1.6.3. Service benchmarking
9.1.6.4. Strategic initiatives
9.1.7. AbbVie
9.1.7.1. Company overview
9.1.7.2. Financial performance
9.1.7.3. Service benchmarking
9.1.7.4. Strategic initiatives
9.1.8. Aurigene Pharmaceutical Services Ltd.
9.1.8.1. Company overview
9.1.8.2. Financial performance
9.1.8.3. Service benchmarking
9.1.8.4. Strategic initiatives
9.1.9. CordenPharma International
9.1.9.1. Company overview
9.1.9.2. Financial performance
9.1.9.3. Service benchmarking
9.1.9.4. Strategic initiatives
9.1.10. Curia Global, Inc.
9.1.10.1. Company overview
9.1.10.2. Financial performance
9.1.10.3. Service benchmarking
9.1.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviation
List of Figures
FIG. 1 Market research process
FIG. 2 Data triangulation techniques
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 QFD modeling for market share assessment
FIG. 6 Market formulation & validation
FIG. 7 High Potency API (HPAPI) Contract Manufacturing Market: Market snapshot
FIG. 8 High Potency API (HPAPI) Contract Manufacturing Market: Market segmentation
FIG. 9 High Potency API (HPAPI) Contract Manufacturing Market Strategy framework
FIG. 10 Parent market outlook
FIG. 11 Related/ancillary market outlook
FIG. 12 High Potency API (HPAPI) Contract Manufacturing Market driver impact
FIG. 13 High Potency API (HPAPI) Contract Manufacturing Market restraint impact
FIG. 14 High Potency API (HPAPI) Contract Manufacturing Market porter’s five forces analysis
FIG. 15 High Potency API (HPAPI) Contract Manufacturing Market PESTEL analysis
FIG. 16 High Potency API (HPAPI) Contract Manufacturing Market segment dashboard
FIG. 17 High Potency API (HPAPI) Contract Manufacturing Market: Product type movement Analysis
FIG. 18 Innovative estimates and forecast, 2018 - 2030 (USD Million)
FIG. 19 Generic estimates and forecast, 2018 - 2030 (USD Million)
FIG. 20 High Potency API (HPAPI) Contract Manufacturing Market segment dashboard
FIG. 21 High Potency API (HPAPI) Contract Manufacturing Market: Application movement Analysis
FIG. 22 Oncology estimates and forecast, 2018 - 2030 (USD Million)
FIG. 23 Hormonal disorders estimates and forecast, 2018 - 2030 (USD Million)
FIG. 24 Glaucoma estimates and forecast, 2018 - 2030 (USD Million)
FIG. 25 Others estimates and forecast, 2018 - 2030 (USD Million)
FIG. 26 High Potency API (HPAPI) Contract Manufacturing Market: Synthesis movement Analysis
FIG. 27 Synthetic estimates and forecast, 2018 - 2030 (USD Million)
FIG. 28 Biotech estimates and forecast, 2018 - 2030 (USD Million)
FIG. 29 High Potency API (HPAPI) Contract Manufacturing Market: Dosage forms movement Analysis
FIG. 30 InjecTable estimates and forecast, 2018 - 2030 (USD Million)
FIG. 31 Oral solids estimates and forecast, 2018 - 2030 (USD Million)
FIG. 32 Creams estimates and forecast, 2018 - 2030 (USD Million)
FIG. 33 Others estimates and forecast, 2018 - 2030 (USD Million)
FIG. 34 Global High Potency API (HPAPI) Contract Manufacturing Market: Regional movement analysis
FIG. 35 Global High Potency API (HPAPI) Contract Manufacturing Market: Regional outlook and key takeaways
FIG. 36 North America market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 37 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 38 Canada market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 39 Europe market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 40 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 41 Germany market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 42 France market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 43 Italy market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 44 Spain market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 45 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 46 China market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 47 Japan market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 48 India market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 49 Australia market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 50 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 51 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 52 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 53 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 54 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 55 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 56 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Companies Mentioned

  • Piramal Pharma Solutions
  • Lonza
  • Catalent Inc
  • VxP Pharma, Inc.
  • Pfizer CentreOne
  • Gentec Pharmaceutical Group
  • AbbVie
  • Aurigene Pharmaceutical Services Ltd.
  • CordenPharma International
  • Curia Global, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages220
PublishedAugust 2022
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 7.32 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.65 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

High Potency API (HPAPI) Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

High Potency API (HPAPI) Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From
Global High Potency API (HPAPI) Contract Manufacturing Market(2023 Edition): Analysis By Formulation (Injectables, Oral Solids, Lotions, Others), End Use, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Image

Global High Potency API (HPAPI) Contract Manufacturing Market(2023 Edition): Analysis By Formulation (Injectables, Oral Solids, Lotions, Others), End Use, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • 200 Pages
  • Global
From
Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Services (Contract Development, Contract Manufacturing), By Region, And Segment Forecasts, 2023-2030 - Product Image

Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Services (Contract Development, Contract Manufacturing), By Region, And Segment Forecasts, 2023-2030

  • Report
  • 175 Pages
  • Global
From
Global High Potency API Contract Manufacturing Market by Product Type (Generics, Innovative), Synthesis (Biotech, Synthetic), Dosage Form, Application - Forecast 2024-2030 - Product Image

Global High Potency API Contract Manufacturing Market by Product Type (Generics, Innovative), Synthesis (Biotech, Synthetic), Dosage Form, Application - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Global Pharmaceutical Contract Manufacturing Market - Forecast to 2030 - Product Image

Global Pharmaceutical Contract Manufacturing Market - Forecast to 2030

  • Report
  • 457 Pages
  • Global
From

About the High Potency API Market

High Potency API Contract Manufacturing is a specialized form of pharmaceutical manufacturing that involves the production of active pharmaceutical ingredients (APIs) with high levels of potency. These APIs are typically used in the production of drugs that require a high degree of safety and efficacy, such as cancer treatments and other complex drugs. The process of high potency API contract manufacturing involves the use of specialized equipment and processes to ensure the highest levels of safety and quality. This includes the use of containment systems, specialized cleaning and sterilization processes, and the use of advanced analytical techniques. High Potency API Contract Manufacturing is a rapidly growing market, driven by the increasing demand for complex drugs and the need for specialized manufacturing processes. Companies in this market include Lonza, Boehringer Ingelheim, Patheon, and Recipharm. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.